People with British coronavirus variant more likely to report these symptoms: survey

People infected with the most transmissible strain of British coronavirus were more likely to report symptoms such as cough, fatigue, muscle aches and sore throats, according to an investigation.

The results of the UK Office for National Statistics were published on Wednesday, on a sample of UK household populations taken between November 15 and January 16.

WHERE IS THE CORONAVIRUS VARIANT IN THE UNITED KINGDOM IN THE UNITED STATES? STATES THAT HAVE IDENTIFIED THE MUTATION – SO FAR

The strain has been dominant in the UK since mid-December, due to its rapid spread, according to Professor Andrew Pollard, director of the Oxford Vaccine Group and chief researcher of the Oxford vaccine trial. The strain is thought to spread about 50% more easily from person to person, and British scientists recently said the strain could be more deadly.

In the new results, survey participants self-reported their symptoms, and the study compared the percentage differences to those that tested positive for another earlier strain.

People infected with the new variant reported an increase in cough of 6.8% (35% vs. 28%), and increases were also seen among the reported symptoms of fatigue, muscle pain and sore throat. of 3.4%, 3.1% and 2.8% respectively. . Fevers were 2.4% higher in people infected with the variant.

ALABAMA CONFIRMS CORONAVIRUS VARIANT IN UK IN 2 CHILDREN, 1 ADULT

During this time, symptoms like loss of smell and taste saw the biggest drops, by 3.5% and 2.9% respectively.

“People who tested positive consistent with the new UK variant were more likely to report classic symptoms and symptoms, but were less likely to report loss of taste and smell,” the survey said. “There is no evidence of a difference in gastrointestinal symptoms, shortness of breath, or headache.”

GET THE FOX NEWS APP

Note that the symptoms have not been professionally diagnosed.

The U.S. Centers for Disease Control and Prevention (CDC) has a total of 315 cases of variant B.1.1.7 in dozens of states. Health experts in the United States have admitted that the number of variant cases is likely underestimated due to the under-monitoring of test samples.